Mirae Asset Global Investments
CAI

Mirae Asset Global Investments’s Caris Life Sciences CAI Stock Holding History

Mirae Asset Global Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
14,717
+1,006
+7% +$22K ﹤0.01% 1034
2025
Q4 		$370K Buy
+13,711
New +$386K ﹤0.01% 1050

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global Investments's CAI Position: Q1 2026 in Review

Mirae Asset Global Investments increased its Caris Life Sciences (CAI) stake by 7.3% in Q1 2026, buying an estimated $22K and bringing the position to 14,717 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Mirae Asset Global Investments first reported a position in CAI in Q4 2025 and has held it in 2 quarters since. The position peaked at $370K in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Mirae Asset Global Investments held 14,717 shares of Caris Life Sciences worth $263K as of Q1 2026.
  • Mirae Asset Global Investments bought 1,006 Caris Life Sciences shares in Q1 2026, an estimated $22K.
  • Caris Life Sciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q1 2026, its #1034 holding.
  • Mirae Asset Global Investments first reported a position in Caris Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Mirae Asset Global Investments's Caris Life Sciences position peaked at $370K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.